How to Judge Peptide Claims Using Real Evidence

Key takeaways

• Named target, downstream pathway, and a reason that pathway would produce the claimed effect. Vague language (“boosts energy,” “reduces inflammation,” “supports immunity”) with no target is marketing, not biology.
• Animal data is not enough. Many molecules look good in rodents and then fail in people. You want controlled human outcomes for the indication you care about.
• How much reaches the blood, how long it lasts, what dose was studied, short- and long-term risks, and what to monitor. Unknown PK + guessed internet doses is a red flag.
• A serious side effect can be acceptable for a lethal disease and unacceptable for a “recovery / beach body / longevity” claim. Risk of doing nothing also matters.
• If a slower, less sexy, better-studied option exists (rehab, approved drug, sleep, training, nutrition), you have to say what the peptide is actually adding.